Source: Nanomedicine. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, NEOPLASIAS MAMÁRIAS, NANOTECNOLOGIA, ANTINEOPLÁSICOS, QUIMIOTERÁPICOS, MELANOMA, FARMACOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, v. 15, n. 26, p. 2539–2542, 2020Tradução . . Disponível em: https://doi.org/10.2217/nnm-2020-0290. Acesso em: 11 out. 2024.APA
Apolinário, A. C., Hirata, A. S., Miguel, R. dos A., Costa-Lotufo, L. V., Pessoa Junior, A., Clair, J. J. L., et al. (2020). Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, 15( 26), 2539–2542. doi:10.2217/nnm-2020-0290NLM
Apolinário AC, Hirata AS, Miguel R dos A, Costa-Lotufo LV, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2024 out. 11 ] Available from: https://doi.org/10.2217/nnm-2020-0290Vancouver
Apolinário AC, Hirata AS, Miguel R dos A, Costa-Lotufo LV, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2024 out. 11 ] Available from: https://doi.org/10.2217/nnm-2020-0290